Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Dr Lal PathLabs IPO is a book built issue of Rs 638.00 crores.
Dr Lal PathLabs IPO bidding started from December 8, 2015 and ended on December 10, 2015. The shares got listed on BSE, NSE on December 23, 2015.
Dr Lal PathLabs IPO price band is set at ₹540 to ₹550 per share. The minimum lot size for an application is 20 Shares. The minimum amount of investment required by retail investors is ₹11,000.
Citigroup Global Markets India Private Limited and Kotak Mahindra Capital Company Limited are the book running lead managers of the Dr Lal PathLabs IPO, while Link Intime India Private Ltd is the registrar for the issue.
Refer to Dr Lal PathLabs IPO RHP for detailed information.
| IPO Date | December 8, 2015 to December 10, 2015 |
| Listing Date | December 23, 2015 |
| Face Value | ₹10 per share |
| Price Band | ₹540 to ₹550 per share |
| Lot Size | 20 Shares |
| Total Issue Size | 11,600,000 shares (aggregating up to ₹638.00 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 82,644,757 |
| Share holding post issue | 82,644,757 |
Dr Lal PathLabs IPO offers 8,120,000 shares. 2,320,000 (28.57%) to QIB, 1,740,000 (21.43%) to NII, 4,060,000 (50.00%) to RII. 203,000 RIIs will receive minimum 20 shares and (sNII) and (bNII) will receive minimum 380 shares. (in case of oversubscription)
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | - | NA |
| QIB Shares Offered | 2,320,000 (28.57%) | NA |
| NII (HNI) Shares Offered | 1,740,000 (21.43%) | |
| Retail Shares Offered | 4,060,000 (50.00%) | 203,000 |
| Total Shares Offered | 8,120,000 (100%) |
Investors can bid for a minimum of 20 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 20 | ₹11,000 |
| Retail (Max) | 18 | 360 | ₹198,000 |
| Lot Size Calculator | |||
The Promoters of the company are:
1. Dr. Arvind Lal;
2. Dr. Vandana Lal; and
3. Eskay House
| Share Holding Pre Issue | 63.67% |
| Share Holding Post Issue | 58.7% |
Dr. Lal PathLabs Limited is a Delhi based provider of diagnostic and related healthcare tests and services in India. Through its nationwide network, company offer patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.
Company has built a national network consisting of its National Reference Laboratory in New Delhi, 163 other clinical laboratories, 1,340 patient service centers and over 5,000 pickup points as of March 31, 2015.
Company's customers include individual patients, hospitals and other healthcare providers and corporate customers.
Highlights:
1. Company offers 3,368 diagnostic and related healthcare tests.
2. Company collected 21.8 million samples from 9.9 million patients in FY 2015.
3. Company is well-positioned to leverage upon one of the fastest-growing segments of the Indian healthcare industry.
4. Its centralized information technology platform fully integrates to it network and is scalable.
| Particulars | For the year/period ended (in Rs. Million) | |||
| 31 Mar 15 | 31 Mar 14 | 31 Mar 13 | 31 Mar 12 | |
| Total Income | 6,401.17 | 5,438.97 | 4,238.61 | 3,199.03 |
| Profit After Tax (PAT) | 879.69 | 739.53 | 488.75 | 410.09 |
| KPI | Values |
|---|---|
| RoNW | 27.85% |
The objects of the Offer are:
1. To achieve the benefits of listing the Equity Shares on the Stock Exchanges and
2. For the Offer for Sale of up to 11,600,000 Equity Shares.
[Dilip Davda]
As this is the first company under consumer healthcare diagnosis services sector having established brand and has no listed peers to compare with, it may enjoy the benefit of first mover of the sector and hence may attract fancy of investors. Although it being an expensive offer, moderate investment for short to medium term may be considered.
Read detail review...The Dr Lal PathLabs IPO is subscribed 33.41 times on December 10, 2015 11:15:00 PM. The public issue subscribed 4.24 times in the retail category, 63.56 times in the QIB category, and 61.28 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 63.56 |
| NII | 61.28 |
| Retail | 4.24 |
| Total | 33.41 |
| Listing Date | December 23, 2015 |
| BSE Script Code | 539524 |
| NSE Symbol | LALPATHLAB |
| ISIN | INE600L01024 |
| Final Issue Price | ₹550 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| BSE |
|---|
| ₹550.00 |
| ₹717.00 |
| ₹715.50 |
| ₹842.40 |
| ₹824.15 |
| NSE |
|---|
| ₹550.00 |
| ₹720.00 |
| ₹711.15 |
| ₹843.70 |
| ₹825.00 |
Dr. Lal PathLabs Limited
Eskay House 54,
Hanuman Road,
New Delhi 110 001, India
Phone: +91 11 3040 3210
Email: cs@lalpathlabs.com
Website: https://www.lalpathlabs.com/
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: drlal.ipo@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html
Dr Lal PathLabs IPO is a main-board IPO of 11,600,000 equity shares of the face value of ₹10 aggregating up to ₹638.00 Crores. The issue is priced at ₹540 to ₹550 per share. The minimum order quantity is 20 Shares.
The IPO opens on December 8, 2015, and closes on December 10, 2015.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Dr Lal PathLabs IPO opens on December 8, 2015 and closes on December 10, 2015.
Dr Lal PathLabs IPO lot size is 20 Shares, and the minimum amount required is ₹11,000.
You can apply in Dr Lal PathLabs IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Dr Lal PathLabs IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Dr Lal PathLabs IPO allotment status.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
IPO Guru (2600+ Posts, 2700+ Likes)
